Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSEC trial of oral cannabis extract for multiple sclerosis spasticity symptoms
2005-005263-29Phase 3Completed
- Sponsor
- GfKF
- Start
- Dec 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nabiximols in multiple sclerosis (MS), sponsored by GfKF. Started Dec 2005; status: completed.
02
Drugs
nabiximols
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-005263-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005263-29.